CannaMD

MARCH 24, 2021

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Researchers Jeremy Mennis and Gerald J.

Treatment 104

Treatment Legalization Marijuana Research and Development 104

Veriheal

AUGUST 15, 2022

This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels. The sessions were logged by a total of 1,224 people who had access to the app. Promising News for Endless Patients.

Treatment 80

Treatment Research and Development Sativa Cannabinoids 80

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

AUGUST 15, 2021

Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.

Medicine 98

Medicine Research and Development Conditions Treatment 98

Cannabis Law Report

DECEMBER 5, 2021

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Vine Ventures have announced the creation of a novel, social impact Special Purpose Vehicle (SPV), called the Regenerative Financing Vine (RFV), that will infuse $70 million into patient access infrastructure and research for MDMA-assisted therapy for PTSD.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Unfortunately, tobacco is easy to access and addiction is hard to curb.

Research and Development 96

Research and Development Therapy Data Treatment 96

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 6, 2021

This collaboration is intended to include research into COMP360 psilocybin therapy and other novel therapies that may be developed by COMPASS in areas of unmet need such as depression, post-traumatic stress disorder (PTSD) and anorexia. George Goldsmith, CEO and Co?founder,

Research and Development 98

Research and Development Clinical Trials Therapy Patients 98

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

JULY 28, 2021

This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

FEBRUARY 14, 2024

The vote passed 7-0 after a group of senators, first responders, and military members held a press conference regarding the benefits and potential of psilocybin, also known as magic mushrooms , for mental health treatment. The goal is to ensure that psychedelic therapy remains safe, accessible, and affordable to those 21 and older.

Therapy 62

Therapy Legalization Research and Development Treatment 62

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JANUARY 31, 2022

TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

APRIL 13, 2022

Delic Labs’ latest exemptions enable the Company to develop innovative analytical methods for psychedelic research. Last year, the lab also applied for a Dealer’s License with the intent of commercializing psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Additionally, they may help slow the growth of certain types of cancer cells, though further research is needed.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

SpeedWeed

AUGUST 16, 2021

Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of ??5-MeO-DMT Clinical studies using psilocybin show huge potential to battle treatment-resistant depression, under the guidance of a therapist.

Research and Development 52

Research and Development Clinical Trials Treatment Conditions 52

Cannabis Law Report

DECEMBER 9, 2021

Nue Life is donating $50,000 to MAPS and $10,000 to the Ketamine Research Foundation. “We believe it is the responsibility of psychedelic-therapy companies to provide material support to the life-changing research being done in the space, which has made our work possible. . MIAMI , Dec.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

MARCH 9, 2022

This license expansion will further position Numinus as a recognized global research centre for natural psychedelic medicines, and supplements the current work Numinus is already undertaking on Psilocybe species and inherent synergistic compounds. Harmaline and harmalol naturally occur in B. caapi , while P. viridis , D.

Research and Development 52

Research and Development Therapy Access Medicine 52

Cannabis Law Report

MAY 12, 2022

Beckley Psytech to collaborate with Lophora on researching New Clinical Entities (NCE’s). Under the terms of the agreement Beckley Psytech will jointly fund continuing development of the Lophora pipeline and collaborate broadly on R&D. Beckley Psytech has been working diligently to build a first-class drug development capability.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Veriheal

SEPTEMBER 23, 2021

Note: Veriheal does not support illegally consuming therapeutic substances such as Iboga but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Is There Any Research on Iboga and Its Medicinal Properties?

Treatment 98

Treatment Medicine Research and Development Therapy 98

PrestoDoctor

JANUARY 30, 2024

By exploring the signs and symptoms, risk factors, mechanism of action, and treatment options for cannabis-induced psychosis, we can better equip ourselves with the knowledge needed to prevent and manage this condition. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms.

Research and Development 52

Research and Development Treatment Conditions Education 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

MMJ Recs

MARCH 28, 2024

Navigating the world of medical marijuana (MMJ) in Iowa can be a daunting task for patients seeking alternative treatments. From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey.

Patients 52

Patients Treatment Research and Development Therapy 52

Veriheal

JUNE 20, 2023

Depression and addiction continue to impact millions of lives worldwide, making the search for effective treatments crucial. In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine.

Medicine 97

Medicine Research and Development Treatment Conditions 97

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JULY 29, 2021

We want to be an industry leader in preventing negative side effects during treatment and believe this can be of benefit to the entire industry.” Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. Media Inquiries: Gabe Rodriguez. Gabe@Ehave.com.

Research and Development 105

Research and Development Conditions Data Patients 105

MMJ Recs

FEBRUARY 10, 2024

Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views. Understanding the specifics of Ohio’s medical cannabis legislation is crucial to appreciating the strides made in facilitating patient access to this alternative form of medicine.

Research and Development 105

Research and Development Marijuana History Legislation 105

MMJ Recs

FEBRUARY 27, 2024

Dispensaries serve as the primary access point for patients seeking medical marijuana products. Currently, Florida has a limited number of dispensaries strategically located across the state to ensure accessibility for patients with qualifying conditions. The severity and progression of symptoms can vary from person to person.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

Puff Puff Post

JANUARY 24, 2019

“There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. The federal government is investing in marijuana research too.

Research and Development 111

Research and Development Legalization Marijuana Recreational 111

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

WeedAdvisor

MARCH 19, 2019

Researchers found that complementary CBD therapy in conjunction with conventional treatment yielded better results. Another thing the researchers noted was that their animals experienced no negative side effects with or without CBD. The doctors involved in the study know that CBD will at least help fill the treatment gap.

Treatment 53

Treatment CBD Research and Development Therapy 53